Barclays PLC Has $1.45 Million Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN)
Barclays PLC grew its holdings in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 14.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,563 shares of the company’s stock after buying an additional 8,346 shares during the quarter. Barclays […]
Barclays PLC grew its holdings in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 14.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,563 shares of the company’s stock after buying an additional 8,346 shares during the quarter. Barclays […]
